Published in AIDS Weekly, October 9th, 2006
Being a late-stage biotech company, the need for strategic intelligence is fundamental for Theratechnologies and, according to Comintell, they now have a tool that helps them identify growth opportunities and gives early warning of competitive threats.
"Theratechnologies has a clear vision of what they want to accomplish with their strategic intelligence work," said Jesper Martell, CEO of Comintell. "In...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.